Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Invested Capital (2016 - 2025)

Acro Biomedical has reported Invested Capital over the past 10 years, most recently at -$386964.0 for Q4 2025.

  • Quarterly results put Invested Capital at -$386964.0 for Q4 2025, down 31.19% from a year ago — trailing twelve months through Dec 2025 was -$386964.0 (down 31.19% YoY), and the annual figure for FY2025 was -$386964.0, down 31.19%.
  • Invested Capital for Q4 2025 was -$386964.0 at Acro Biomedical, up from -$432619.0 in the prior quarter.
  • Over the last five years, Invested Capital for ACBM hit a ceiling of $886444.0 in Q1 2021 and a floor of -$432619.0 in Q3 2025.
  • Median Invested Capital over the past 5 years was $50020.5 (2023), compared with a mean of $143998.4.
  • Biggest five-year swings in Invested Capital: fell 2.91% in 2022 and later crashed 181.38% in 2024.
  • Acro Biomedical's Invested Capital stood at $664448.0 in 2021, then fell by 14.94% to $565196.0 in 2022, then tumbled by 145.47% to -$257014.0 in 2023, then decreased by 14.77% to -$294972.0 in 2024, then crashed by 31.19% to -$386964.0 in 2025.
  • The last three reported values for Invested Capital were -$386964.0 (Q4 2025), -$432619.0 (Q3 2025), and -$317520.0 (Q2 2025) per Business Quant data.